Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

NCT00072774 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: DVS-233 SR

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer